Hu Chunbo, Yu Huiqian, Ye Min, Shen Xia
Chunbo Hu, M.D., is Pharmacy Resident; Huiqian Yu, M.D., is Pharmacy Resident; Min Ye, M.D., is Pharmacy Resident; and Xia Shen, M.D., is Associate Professor, Department of Anesthesiology, The Eye, Ear, Nose and Throat Hospital of Fudan University, Shanghai Medical College of Fudan University, Shanghai, China.
Am J Health Syst Pharm. 2014 Jul 1;71(13):1108-1011. doi: 10.2146/ajhp130473.
The effects of i.v. remifentanil in combination with an inhaled anesthetic to facilitate tracheal extubation of deeply anesthetized adults after otologic surgery are investigated.
Fifty patients undergoing middleear surgery were recruited for the study. All patients were administered deep anesthesia (i.v. fentanil, propofol, and mivacurium) and intubated, with subsequent administration of inhaled sevoflurane for anesthesia maintenance. Prior to endotracheal tube removal, the patients received i.v. dexamethasone, ondansetron hydrochloride, and parecoxib and were randomly allocated to two groups. In group S (n = 25), anesthesia was maintained with sevoflurane alone (1.3 times the minimum effective alveolar concentration [MAC]), while patients in group SR (n = 25) received low-dose i.v. remifentanil and a reduced dose of sevoflurane (1.0 MAC).
The mean remifentanil dosage was 0.028 μg/kg per minute. Relative to patients in group S, patients in group SR had a significantly lower mean respiratory rate (6.4 breaths per minute versus 15.8 breaths per minute, p < 0.01) and end-tidal carbon dioxide pressure (48.1 mm Hg versus 52.1 mm Hg, p < 0.05) after extubation. Postextubation airway obstructions requiring nasal airway placement were less frequent in group SR (14 cases versus 2 cases in group S, p < 0.05); patients in group SR also had a shorter mean time to awakening (19.5 minutes versus 15.8 minutes, p < 0.05) and a shorter mean time to orientation (31.4 minutes versus 26.1 minutes, p < 0.05).
Sevoflurane combined with remifentanil provided rapid recovery and appeared to be safe for deep-anesthesia tracheal extubation in adult patients after otologic surgery.
研究静脉注射瑞芬太尼联合吸入麻醉药对促进耳科手术后深度麻醉的成年患者气管拔管的效果。
招募50例接受中耳手术的患者进行本研究。所有患者均接受深度麻醉(静脉注射芬太尼、丙泊酚和米库氯铵)并插管,随后吸入七氟烷维持麻醉。在拔除气管导管前,患者接受静脉注射地塞米松、盐酸昂丹司琼和帕瑞昔布,并随机分为两组。S组(n = 25)仅用七氟烷维持麻醉(1.3倍最低肺泡有效浓度[MAC]),而SR组(n = 25)患者接受低剂量静脉注射瑞芬太尼和减少剂量的七氟烷(1.0 MAC)。
瑞芬太尼平均剂量为每分钟0.028μg/kg。与S组患者相比,SR组患者拔管后平均呼吸频率显著更低(6.4次/分钟对15.8次/分钟,p < 0.01),呼气末二氧化碳分压也更低(48.1 mmHg对52.1 mmHg,p < 0.05)。SR组需要放置鼻气道的拔管后气道梗阻发生率更低(14例对S组的2例,p < 0.05);SR组患者平均苏醒时间也更短(19.5分钟对15.8分钟,p < 0.05),平均定向时间更短(31.4分钟对26.1分钟,p < 0.05)。
七氟烷联合瑞芬太尼可实现快速恢复,且似乎对耳科手术后成年患者的深度麻醉气管拔管是安全的。